Albeda Research is a contract research organisation (CRO) offering metabolic studies with specialised NMR equipment (hyperpolarised NMR). The CRO builds on more than 15 years research and development of the dissolution dynamic nuclear polarisation technique (dDNP).

Albeda Research is partially located at BIO, with their laboratory neighbouring the new 600 MHz instrument in the Section for Biomolecular Sciences. Albeda is currently engaged in product development of a breast cancer diagnosis (HYPEMET) supported by funding from Innovation Fund Denmark.

Link to Albeda home page